Report : Middle East & Africa Aesthetic Medical Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology {Laser-Based (Alexandrite, Diode, ND:YAG, CO2, ER:YAG, PDL, and Others), Light-Based (IPL and LED), Electromagnetic Energy-Based [Infrared-Based, Radiofrequency-Based, Non-Laser (Hydradermabrasion), and Others], Ultrasound-Based, Cryolipolysis, Suction-Based, and Plasma Energy-Based}, Application (Facial Skin Resurfacing, Photorejuvenation, Hair Removal, Fat Reduction and Body Contouring, Skin Tightening, Cellulite Reduction, Feminine Rejuvenation, Tattoos and Pigmentation, Acne & Acne Scars, Vascular Lesions, and Others), and End User (Dermatology and Cosmetic Clinics, Hospitals and Clinics, Medical Spas, and Home Use)
At 10.7% CAGR, the MEA Aesthetic Medical Devices Market is speculated to be worth US$ 1,202.23 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the MEA aesthetic medical devices market was valued at US$ 654.88 million in 2022 and is expected to reach US$ 1,202.23 million by 2028, registering an annual growth rate of 10.7% from 2022 to 2028. Technological advancements associated with medical aesthetic devices and new product launches & approvals are the critical factors attributed to the market expansion.
All medical devices used for various cosmetic procedures, including plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, etc., are categorized under the medical aesthetic products umbrella. Technological advancements in devices, increasing awareness about aesthetic procedures, growing acceptance of minimally invasive devices, and a surge in an obese population are the main forces boosting the aesthetics medical devices market growth. With the establishment of the advanced, high-speed internet infrastructure and the growing trend of social media, information is becoming more accessible to everyone, and people are becoming more aware of aesthetic procedures. An increasing number of social media users and the sensitization of the masses to medical aesthetic procedures are being correlated with the improved sales of aesthetic medical devices. The aesthetic outcome in patient demand for cosmetic treatments was influenced by several parameters, such as clinical improvement after surgery, risks and potential complications, and downtime. These parameters could validate plasma technology as a new regenerative modality. The plasma skin regeneration (PSR) technology has great potential in dermatology; it helps treat facial arrhythmias, sun keratosis, seborrheic keratosis, and warts. A few studies have examined the clinical effects of PSR technology on periorbital rejuvenation. With conventional blepharoplasty, more than 90% improvement and with PSR ~20% and 30% improvement in the tightening of the upper eyelid and the periorbital folds, respectively, were achieved. After six months, ~40% improvement in acne scars on the face was achieved after the single PSR treatment. PSR has also been explored for the rejuvenation of the skin of the chest, neck, and back of the hands. In addition, it can be used to treat traumatic scars, benign familial pemphigus, and porokeratosis. Understanding the impact of the PSR technology on aesthetic medicine requires basic knowledge of physics and histopathological aspects of plasma. Recent technological advancements are likely to bring dramatic improvements in the aesthetic treatment of the skin. The emergence of laser and light-based technologies are very promising among skin rejuvenation therapies. New laser resurfacing techniques for skin rejuvenation offers significant advantages over conventional ablative lasers such as the CO2 and erbium-YAG laser systems. Non-ablative and fractional lasers, although not as effective as ablative therapies, are associated with significantly lower complication rates and shorter recovery periods. New devices combining ablative and fractional technologies are available in the medical aesthetics market, showing remarkable results.
On the contrary, risks and complications associated with procedures and stringent safety regulations hurdles the growth of MEA aesthetic medical devices market.
- Based on technology, the MEA aesthetic medical devices market is segmented into laser-based, light-based, electromagnetic energy-based, ultrasound-based, cryolipolysis, suction-based, and plasma energy-based. The laser-based segment held 24.2% market share in 2022, amassing US$ 158.70 million. It is projected to garner US$ 294.31 million by 2028 to expand at 10.8% CAGR during 2022–2028.
- Based on application, the MEA aesthetic medical devices market is segmented into facial skin resurfacing, photo rejuvenation, hair removal, fat reduction & body contouring, skin tightening, cellulite reduction, feminine rejuvenation, tattoos & pigmentation, acne & scars, vascular lesions, and others. The acne and acne scars segment held 19.0% market share in 2022, amassing us$ 124.30 million. it is projected to garner US$ 221.78 million by 2028 to expand at 10.1% CAGR during 2022–2028.
- Based on end user, the MEA aesthetic medical devices market is segmented into dermatology & cosmetic clinics, hospitals and clinics, medical spas and home use. The dermatology and cosmetic clinics segment held 36.9% market share in 2022, amassing US$ 241.89 million. It is projected to garner US$ 454.96 million by 2028 to expand at 11.1% CAGR during 2022–2028.
- Based on country, the MEA aesthetic medical devices market is segmented into Saudi Arabia, South Africa, UAE, and Rest of MEA. Our regional analysis states that Saudi Arabia captured 46.2% market share in 2022. It was assessed at US$ 302.77 million in 2022 and is likely to hit US$ 550.03 million by 2028, exhibiting a CAGR of 10.5% during the forecast period.
Key players dominating the MEA aesthetic medical devices market are Alma Lasers (Sisram Medical), Asclepion Laser Technologies GmbH, Bausch Health Companies Inc., Candela Corporation, Cutera Inc., Fotona, InMode, Jeisys Medical Inc, LASEROPTEK, Lumenis Be Ltd., Lutronic, Merz Pharma, Mesoestetic, and Venus Concept among others.
- In 2021, BTL, announced that its Emsculpt family of products is the fastest aesthetic device brand to reach one million treatments.
- In 2021, InMode Ltd. announce the launch of the EvolveX platform with Transform technology. EvolveX is a hands-free, zero downtime full body transforming solution equipped with clinically proven technologies to remodel skin, treat fat, and sculpt muscles. The versatility of EvolveX multi-modalities allows physicians to focus on individual patient needs and produce consistent transformative results.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com